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Photoreceptor perturbation around subretinal drusenoid 
deposits revealed by adaptive optics scanning laser 
ophthalmoscopy
Yuhua Zhang1,*, Xiaolin Wang1, Ernesto Blanco Rivero1, Mark E Clark1, Clark Douglas 
Witherspoon1, Richard F Spaide2, Christopher A. Girkin1, Cynthia Owsley1, and Christine 
A. Curcio1
1Department of Ophthalmology, University of Alabama at Birmingham School of Medicine, 
Birmingham, Alabama
2Vitreous-Retina-Macula Consultants of New York, New York
Abstract
Purpose—To describe the microscopic structure of photoreceptors impacted by subretinal 
drusenoid deposits, also called pseudodrusen, an extracellular lesion associated with age-related 
macular degeneration (AMD), using adaptive optics scanning laser ophthalmoscopy (AOSLO).
Design—Observational case series.
Methods—Fifty-three patients with AMD and 10 age-similar subjects in normal retinal health 
were recruited. All subjects underwent color fundus photography, infrared reflectance, red-free 
reflectance, autofluorescence, and spectral-domain optical coherence tomography (SD-OCT). 
Subretinal drusenoid deposits were classified with a 3-stage OCT-based grading system. Lesions 
and surrounding photoreceptors were examined with AOSLO.
Results—Subretinal drusenoid deposits were found in 26 eyes of 13 patients with AMD and 
imaged by AOSLO and SD-OCT in 18 eyes (n=342 lesions). SD-OCT showed subretinal 
drusenoid deposits as highly reflective material accumulated internal to the retinal pigment 
epithelium. AOSLO revealed that photoreceptor reflectivity was qualitatively reduced by stage 1 
subretinal drusenoid deposits and greatly reduced by stage 2. AOSLO presented a distinct 
structure in stage 3, a hyporeflective annulus consisting of deflected, degenerated or absent 
photoreceptors. A central core with a reflectivity superficially resembling photoreceptors is 
formed by the lesion material itself. A hyporeflective gap in the photoreceptor ellipsoid zone on 
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either side of this core shown in SD-OCT corresponded to the hyporeflective annulus seen by 
AOSLO.
Conclusions—AOSLO and multimodal imaging of subretinal drusenoid deposits indicate solid, 
space filling lesions in the subretinal space. Associated retinal reflectivity changes are related to 
lesion stages and are consistent with perturbations to photoreceptors, as suggested by histology.
INTRODUCTION
Pseudodrusen were first described by Mimoun et al as a distinctive yellowish pattern that 
was “visible en lumière bleue” (visible in blue light) in some eyes with age-related macular 
degeneration (AMD).1 Because the lesions appeared different from typical drusen and were 
angiographically silent, the authors thought they were deep to the retinal pigment epithelium 
(RPE). Arnold and Sarks found that pseudodrusen were more easily visualized with red-free 
(RF) light or with a He-Ne laser scanning laser ophthalmoscope (SLO).2 On the basis of one 
histological specimen lacking neurosensory retina, they proposed that pseudodrusen 
appearance arose from choroidal fibrosis. Lois et al described a reticular pattern of 
autofluorescence in eyes with AMD.3 Smith et al reported that 87.5% of eyes with a 
reticular autofluorescence pattern also had pseudodrusen corresponding in part with the 
autofluorescence,4 later speculating that both phenomena were manifestations of a reticular 
macular disease involving the RPE, choriocapillaris, and inner choroidal.5 With spectral 
domain optical coherence tomography (SD-OCT), Zweifel et al found that pseudodrusen 
correlated to granular hyper-reflective materials deposited anterior to the RPE in the 
subretinal space;6 other than generalized choroidal thinning, no specific choroidal 
abnormality was seen. By comparing OCT findings to histologic examination of 1 donor 
retina with extracellular material between the RPE and photoreceptors called subretinal 
drusenoid deposits,7 Zweifel et al attributed pseudodrusen appearance to these lesions. 
Subsequent SLO and OCT imaging studies reached the same conclusion.8, 9 However, 
Sohrab et al stated that subretinal deposits and photoreceptor disturbances on OCT did not 
co-localize with pseudodrusen and speculated how pseudodrusen appearance could arise 
secondarily from choroidal fibrosis.10 Suzuki et al recently defined 3 subtypes of clinical 
pseudodrusen, all corresponding to a subretinal reflectivity visible by OCT.11 Thus the 
location of pseudodrusen within the chorioretinal layers has been a subject of debate, with 
evidence for the subretinal space accumulating.
In clinicopathologic studies, Sarks et al showed that membranous debris, the principal 
component of soft drusen and basal linear deposit, was also found in the subretinal space.12 
Curcio and co-workers demonstrated that these subretinal materials shared partial molecular 
commonality with drusen, including unesterified cholesterol, apolipoprotein E, complement 
factor H, and vitronectin. Esterified cholesterol, however, was undetectable, as was 
immunoreactivity for photoreceptor, Müller cell, and RPE marker proteins.7, 13 Subretinal 
drusenoid deposits were proposed as the correlate to pseudodrusen by these authors, because 
the size, distribution, and prevalence of the material seen in a series of 22 donor eyes 
corresponded so closely to pseudodrusen imaged clinically by several methods.14 In one 
case reported by the Sarks and coworkers, an eye with pseudodrusen was examined 
histologically and found to correlate with subretinal material.15 These authors declined to 
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attribute all pseudodrusen to such deposits, however, because the smallest ones were not 
detectable clinically.
Given the paucity of histologic examination of clinically characterized eyes, two recent 
advances in ocular imaging have made it possible to address questions of pseudodrusen 
localization in vivo. First, the living retina can be imaged with significantly improved 
resolution and precision in three dimensions. SD-OCT can image cross-sections of retina 
and choroid with sufficient resolution to reveal cellular and subcellular stratifications.16, 17 
A recent study has demonstrated the feasibility of using adaptive optics (AO) to image cones 
in the maculae of patients with pseudodrusen.18 However, the study was conducted with a 
flood-illuminated AO imaging system that does not possess depth discrimination capability. 
AO assisted confocal SLO (AOSLO)19–24 has improved depth discrimination ability to form 
images from light emanating from the selected plane in the fundus. Multimodal imaging 
featuring AOSLO thus has the potential to answer whether the histological correlates of 
pseudodrusen are in the subretinal space. Secondly, information from multiple imaging 
technologies can be readily merged to bring the advantages of each individual technique to 
bear on a single question, resulting in a more comprehensive understanding. Therefore, the 
purpose of the present study was 2-fold: to correlate AOSLO findings with SD-OCT to 
precisely determine the laminar localization of pseudodrusen and to investigate how the 
AOSLO findings inform the imaging characteristics of pseudodrusen obtained by other more 
established modalities.
METHODS
The study followed the tenets of the Declaration of Helsinki and was approved by the 
Institutional Review Board at the University of Alabama at Birmingham. Written informed 
consent was obtained from participants after the nature and possible consequences of the 
study were explained. The study complied with the Health Insurance Portability and 
Accountability Act of 1996.
• Nomenclature: In previous studies, the terms reticular pseudodrusen, pseudo-
reticular drusen, or pseudodrusen was used for different en face 
modalities2, 8, 15, 25–32, and the term subretinal drusenoid deposits for cross-
sectional histology and SD-OCT6, 7, 32, 33 In the present article, we will use the 
term pseudodrusen for standard en face ophthalmoscopy (color fundus 
photography, infrared reflectance (IR), red-free (RF), and autofluorescence (AF)) 
and the term subretinal drusenoid deposits for the collections of material seen in the 
subretinal space in histologic specimens, AOSLO, and OCT.
• Patients and controls: Study patients with AMD and age-similar subjects with 
normal retinas were recruited from the clinical research registry of the Department 
of Ophthalmology of the University of Alabama at Birmingham and through the 
Retina Service. The patients have been diagnosed with AMD previously. To assess 
the disease severity, stereoscopic color digital 30° fundus photographs were taken 
with a FF450 Plus fundus camera (Carl Zeiss Meditec, Dublin, CA) after pupil 
dilation, and photographs were graded by a masked, experienced grader using the 
Age-Related Eye Disease Study 2 (AREDS2) severity scale for AMD.34 Disease 
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severity ranged from early to advanced (AREDS grade 2–11). Participants in 
normal macular health met the criteria for AREDS grade 1 in both eyes. Exclusion 
criteria included diabetes, history of retinal vascular occlusions, and any signs or 
history of hereditary retinal dystrophy. Subjects were also excluded for reasons that 
might potentially prevent successful imaging, such as poor fixation, significant 
media opacity, irregular pupil shape, poor dilation, or refractive errors beyond ±6 D 
spherical and ±3 D cylinder. The inclusion criteria for normal comparison subjects 
were the same, with the additional criteria of age greater than 50 years, no 
clinically significant cataract, and best-corrected visual acuity (BCVA) of 20/25 or 
better.
• High-resolution AOSLO imaging: Imaging was conducted with a new generation 
AOSLO that was developed in our lab, as described.35, 36 This instrument was 
based upon an earlier prototype that used a micro-electric-mechanic-system based 
deformable mirror.20 The new instrument addressed several major obstacles that 
impede imaging of older patients with AMD. First, the pupil size decreases and 
wavefront aberration increases with aging. Second, many older patients have 
cataract, which significantly affects wavefront detection and impairs AO wavefront 
correction. Third, in patients with intraocular lenses, it is very common that 
proliferation and transformation of lens epithelial cell remnants lead to posterior 
capsular opacification or fibrosis over the intraocular lens. While capsulotomy can 
make an opening on the opacified posterior capsule, the clear pupil for imaging 
often has an irregular shape. This may not only reduce the useful pupil size but also 
cause complicated light scattering that impedes AO operation.
To address these challenges, we developed advanced wavefront detection and 
correction strategy. We designed a high-speed Shack-Hartmann wavefront sensor 
based upon a complementary metal–oxide–semiconductor (CMOS) camera 
(MicroVista®-NIR, Intevac Inc. CA). The camera’s spectral response is optimized 
for the imaging light used by AOSLO, enabling the AO system to be operated at a 
loop frequency up to 100 Hz. Most previously reported AO systems for retinal 
imaging run under 30 Hz. High-speed wavefront sensing significantly facilitates 
advanced control strategy based upon Zernike mode correction, thereby allowing 
for AO correction of wavefronts in eyes with the optical problems described above. 
Furthermore, we adopted a high-speed deformable mirror (Hi-Speed DM97-15, 
ALPAO SAS, France) with 97 actuators with stroke up to 30 which provides 
improved ability37 to compensate for increased high orders and amplitude of 
wavefront aberration due to aging.38 The AOSLO pupil size was set at 5.6 mm in 
diameter. After AO correction, the root-mean-square wave aberration was reduced 
to less than 0.05 μm in most eyes, reaching the criterion for diffraction-limited 
resolution for the light used in imaging. A low coherence light source, a 
superluminescent diode (Broadlighter S840-HP, Superlum, Russia), was employed 
for producing high fidelity retinal images.39 The imaging light power measured at 
the cornea was 500 μWatts, which is about 1/26 of the maximum permitted 
exposure limits set by the ANSI standard.40 The AOSLO records continuous videos 
from the eye with a frame rate 15 Hz.
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All participants underwent BCVA measurement by the Electronic Visual Acuity 
(EVA) protocol.41 Pupils were dilated with 1.0% tropicamide and 2.5% 
phenylephrine hydrochloride. The subject’s head was aligned and stabilized using a 
head-mount with a chin-rest. A fixation target consisting of a moving bright green 
light dot formed by the light from a laser diode (DJ532-10- 532, Thorlabs Inc, 
Newton, NJ) on a calibrated grid. The grid, on white paper, was placed in front of 
the eye via a pellicle beam splitter (BP208, Thorlabs Inc, Newton, NJ) to help the 
subject’s fixation. The wavelength of the diode laser is 532 nm and the light was 
coupled into a single mode fiber and collimated to form a light dot of 1.5 mm 
diameter on the grid paper. The light power was adjusted to 2 mW at the output of 
the fiber. The subject saw the light dot on the back of the grid paper through the 
pellicle beam splitter. During imaging, the dot was moved on the grid paper to 
direct the subject’s view angle. At each grid point, the light dot stopped for 3–5 
seconds so that 45–75 frames were acquired. Videos were recorded continuously 
across an area of 15 X 15°. An AOSLO imaging session lasted approximately 1 
hour. Data presented were collected from one imaging session for each subject. 
Before images were recorded, the gain of the AOSLO photo-detector was titrated to 
obtain proper image brightness and contrast according to a real-time histogram of a 
retinal video and remained constant through the whole imaging session.
• AOSLO image processing, and analysis: Image distortions caused by 
nonlinearities in the resonant scanner and by eye movements were eliminated by 
customized software.42 Registered images were averaged to enhance signal-to-
noise ratio. Images of different retinal locations were manually aligned on a cell-to-
cell basis to create a continuous montage (Photoshop, Adobe Systems Inc., 
Mountain View, CA).
AOSLO image pixel size was computed from an image of a precisely calibrated dot 
grid placed at the retinal plane of a model eye. The extent of retina affected by the 
underlying subretinal drusenoid deposits at different progression stages was 
measured at multiple locations using the Ruler Tool of Photoshop and then 
averaged.
• Multimodal imaging: In addition to stereoscopic color digital 30° fundus 
photographs, en face IR (λ = 830 nm), RF (λ = 560 nm), and AF (excitation, 488 
nm; emission, > 600 nm) images were acquired with the confocal SLO of the 
Spectralis (Heidelberg Engineering, Carlsbad, CA). Fields of view of 30° × 30° 
were digitized at 768 × 768 pixels. Retinal cross-sections were imaged with the 
Spectralis SD-OCT (λ = 870 nm; acquisition speed, 40,000 A-scans per seconds; 
scan depth, 1.9 mm; digital depth resolution, 3.5 μm per pixel in tissue; lateral 
resolution in tissue 14 μm). In each study eye, 97 B-scans were acquired across a 
15° × 10° area of the central macula to create a volume.
• Pseudodrusen identification: Multiple imaging modalities can disclose 
pseudodrusen, with different specificity and sensitivity.30 It is recommended that 
detection should be confirmed using more than one modality for improving 
accuracy.30, 31 The identification of pseudodrusen in our study was based on their 
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presence in at least 2 en face imaging modalities and in SD-OCT.27, 29, 32 In en 
face imaging, pseudodrusen appear as an interlacing collection of ribbons or a dot-
like pattern of yellow-white lesions (in color fundus photography), a pattern of 
hypo-reflective or hyper-reflective spots (in IR reflectance), or a pattern of small 
hypo-autofluorescent areas against a background of mild hyper-autofluorescence 
(in AF). Although a reticular pattern was often seen in color photography, it was 
not a criterion for diagnosis. In SD-OCT, subretinal drusenoid deposits were hyper-
reflective mounds internal to the RPE. Axial microstructure and location of 
subretinal drusenoid deposits were evaluated with SD-OCT, using the 
nomenclature of Spaide and Curcio for the 4 outer retinal hyper-reflective 
bands.43–45
• Multimodal image registration: Color fundus photographs and IR, RF, AF 
images taken with the Spectralis SLO were registered manually by use of retinal 
vessels and capillaries as invariant landmarks. Color fundus photographs and the 
SLO IR image were then magnified and registered with the AOSLO montage by 
use of retinal vessels and capillaries as landmarks. Then pseudodrusen apparent on 
standard funduscopy were localized in AOSLO images and examined with high 
resolution.
• Subretinal drusenoid deposits classification: Lesions were scored with the 3-
stage grading system introduced by Zweifel et al.6 Specific lesions at each stage 
and surrounding photoreceptors were examined by AOSLO and by en face OCT.
RESULTS
A total of 63 subjects (33 males and 30 females) were enrolled from October 2010 to 
January 2013, including 53 AMD patients (73.50 ± 8.08 years, mean ± SD) and 10 control 
subjects (64.0 ± 9.93 years). All subjects were white and non-Hispanic. Subretinal drusenoid 
deposits were found in 26 eyes of 13 AMD patients (13/53: 24.5%). One eye (1/26: 4%) was 
at AREDS grade 4 (early stage); 16 eyes (16/26: 62%) were at AREDS grade 5–8 
(intermediate stage); 4 eyes (4/26: 15%) were at AREDS grade 9–10 (advanced stage, GA); 
5 eyes (5/26: 19%) were at AREDS grade 11 (advanced stage, CNV). Eleven patients had 
both subretinal drusenoid deposits and conventional sub-RPE drusen, and 2 patients had 
only subretinal drusenoid deposits. AOSLO imaged 18 eyes from 11 patients. Two (4 eyes) 
patients were not imaged by AOSLO due to small pupil (subject 2, AREDS OD:5, OS:5) 
and poor fixation (subject 7, AREDS OD:11, CNV, OS:9, GA). No subretinal drusenoid 
deposits were found in eyes at AREDS grade 1.
Figure 1 shows images of a normal subject. AOSLO revealed clearly the mosaic of cone and 
rod inner segments across the macula. While individual photoreceptors manifested varying 
brightness,46, 47 brightness is similar across clusters of adjacent photoreceptors; accordingly, 
SD-OCT revealed even and well-aligned outer retinal hyper-reflective bands without 
discernible hyper-reflective material between RPE and EZ bands.
The effects of subretinal drusenoid deposits on surrounding cells were readily imaged with 
AOSLO at different lesion stages. At stage 1 (Figure 2), the EZ band undulates due to a 
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granular hyper-reflective material accumulated between it and the RPE band. The overlying 
photoreceptors exhibit reduced reflectivity, and the mosaic is undetectable by AOSLO. At 
stage 2 (Figure 3), the EZ band was appreciably deflected inwardly by mounds of 
accumulated material. The retina superjacent to each lesion shows further reduced overall 
reflectance, and individual photoreceptors are no longer visible by AOSLO. At stage 3 
(Figure 4), subretinal drusenoid deposits have interrupted the EZ band and extended to the 
inwardly deviated ELM. Surrounding the lesion apex is a region of absent OCT signal from 
the EZ and a lack of visualized cones. By AOSLO, the retina immediately adjacent to 
subretinal drusenoid deposits shows a hyporeflective annular zone with indistinct 
photoreceptors, which corresponds to the hyporeflective EZ gaps. As discussed in the next 
section, this annular zone may contain missing, degenerated, or deflected photoreceptors. 
AOSLO also reveals within the annulus a reflective center area with a granular structure that 
is similar to the surrounding retina (bottom left panel of Figure 4, and top panel of Figure 5). 
Outside the annulus the cone mosaic resumes, albeit at variable reflectivity levels relative to 
normal photoreceptors (Figure 1). En face OCT imaging (Figure 5, bottom row) of a large 
solitary subretinal drusenoid deposit also shows a hyporeflective annulus of the stage 3 
lesion like that revealed by AOSLO. The hyper-reflective center in AOSLO imaging is the 
subretinal drusenoid deposit material itself, as confirmed by en-face reconstruction of OCT 
scans (Figure 5, bottom row), as well as AO assisted SD-OCT.36
We assessed by AOSLO 342 subretinal drusenoid deposits that could also be identified on 
SD-OCT scans and all localized to the subretinal space. Of these, 63 could be classified as 
stage 1, 118 stage 2, and 171 stage 3. Subretinal drusenoid deposits associated impact on 
photoreceptors by stages is shown in the Table, which lists the diameters of the quasi-
circular areas of overlying retina affected by individual deposits. The inner diameters of 
stage 3 subretinal drusenoid deposits’ reflective cores are the diameters of lesions 
themselves.
DISCUSSION
Using AOSLO, we observed that defined stages of subretinal drusenoid deposits were 
associated with reflectivity changes consistent with perturbed surrounding photoreceptors. 
AOSLO revealed a distinct en face structure of stage 3 subretinal drusenoid deposits 
(Figures 4–5) with a hyporeflective annular zone containing indistinct photoreceptors and 
surrounding a reflective central area. AOSLO imaging in conjunction with SD-OCT 
suggested that the hyporeflective annulus likely consists of photoreceptors with deflected, 
degenerated, or missing inner or outer segments, and the reflective core of stage 3 lesions is 
the subretinal drusenoid deposits material itself.
Our results are informed by the imaging mechanism of AOSLO, which draws on principles 
of confocal microscopy 48 and waveguide properties of photoreceptors.49, 50 The 
photoreceptors of the living human eye have waveguiding properties, as evidenced by the 
Stiles–Crawford effect observed for light incident near the pupil rim,51 and by the 
directional component of light reflected off the retina in the related optical Stiles–Crawford 
effect (OSCE).52, 53 In a normal eye the photoreceptors are oriented with their central axis 
toward a point near the pupil center. This is the configuration that allows the photoreceptors 
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to couple the incident light with the highest efficiency. AOSLO is essentially a confocal 
microscope that uses the human eye as its objective lens. To produce a clear photoreceptor 
mosaic, AOSLO imaging light is focused at the anterior aspect of the inner segments,39 near 
the ELM. This is the anatomic axial position where light enters and emerges from the fiber-
optic portion of the photoreceptor.54 AOSLO has an axial resolution of 50–70 μm with the 
AO correction for ocular optical wave aberration,20, 23 implying that AOSLO images are 
formed by the aggregate light reflected from an axial (3D) volume (3 μm x 3 μm x 50 μm 
with our AOSLO) from the ELM to the apical surface of the RPE (Figure 5, middle-right 
panel, levels 1–4), i.e., the portion of the inner and outer segments of the photoreceptors. 
Structures outside of this volume are not imaged.48 In a normal eye, the OSCE produces a 
peaked intensity distribution of directional light returned from the photoreceptor toward the 
pupil center.55–57 The directional light returned from the photoreceptor is caught by the 
AOSLO thus normal orientation of the photoreceptors plays an important role in forming a 
clear image of them. In other words, only those photoreceptors maintain normal alignment 
can be imaged by the AOSLO. In a healthy retina, photoreceptors pack tightly in a matrix 
with their normal orientation toward to the pupil center thus the AOSLO renders a clear 
mosaic of the photoreceptor inner segments across the retina (Figure 1). A large dark area, 
such as the hyporeflective annulus revealed around the stage 3 subretinal drusenoid deposit, 
with indistinct photoreceptors in an AOSLO image may thus imply that photoreceptors are 
with misaligned, or degenerate, or even missing inner or outer segments. A deflected 
photoreceptor is neither able to funnel incident light into inner and outer segments nor 
reflect light back towards the AOSLO detector, thus leading to undetectability. Similarly, for 
a photoreceptor with a degenerating or missing outer segment and a subsequently 
degenerating inner segment, light for imaging will be reduced or absent. This point can be 
explained by a model attributing AOSLO images of photoreceptors to light reflected mostly 
from the EZ and outer segment tips.39 Recently, Meadway et al used directional OCT, a 
technique proposed by Lujan et al,58 to preliminarily confirm that the hyporeflective annulus 
surrounding stage 3 subretinal drusenoid deposits contains deflected photoreceptors 
(Meadway A, et al. IOVS 2014;55:ARVO E-Abstract 1592).
One interesting question is why the EZ appears intact over stage 1 and 2 lesions in OCT, 
when reflectivity revealed by AOSLO over these lesions is clearly reduced. Several 
phenomena may contribute to this finding. The OCT instrument used in this study has a 
lateral resolution of 14 μm. The diameter of the lateral point spread function of the OCT 
(diameter of the light focus waist) is 28 μm, which covers approximately 25 times more 
photoreceptors than the AOSLO light focus (diameter of 5.6 μm). Thus, as long as some 
cones appear, OCT will show a bright pixel, formed by light from a thick slab of the retina, 
and EZ bands over stage 1 and 2 subretinal drusenoid deposits will appear visible and 
continuous. Further, OCT forms images with a coherent detection mechanism that uses a 
reference beam that multiplies the signal from the reflections. B-scans presented in figures 
have been averaged for 36 frames, significantly improving the signal to noise ratio. Finally 
and very importantly, the OCT images are rendered in logarithmic grey scale. All these 
factors contribute to photoreceptors being more visible in the EZ band (imaged by OCT) 
than they are by AOSLO.
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Our study can be compared to and differentiated from the recent report of markedly 
decreased reflectivity attributable to photoreceptors over subretinal drusenoid deposits by 
Mrejen et al, who used a commercial flood illumination AO fundus camera.18 We imaged a 
larger sample of lesions (342 vs 55 subretinal drusenoid deposits) in more eyes (18 vs 11) 
and assessed reflectivity changes with respect to an SD-OCT based grading scale for these 
lesions. Our study suggests that the reflective spots over subretinal drusenoid deposits 
reported by these authors may have included non-photoreceptor reflectivity that can be 
attributed to the lesion itself as well as photoreceptors. Compared to the instrument used by 
Mrejen et al, our AOSLO system has confocal imaging, more actuators on the deformable 
mirror, a high speed wavefront sensor, and a low coherent light source with broader 
spectrum (center wavelength 840 nm, bandwidth 60 nm) to further reduce interference 
artifacts.35, 36, 39 With these technical advantages we observed that the packing density of 
granules in the centers of stage 3 subretinal drusenoid deposit was similar to or higher than 
that of presumably healthy photoreceptors outside the dark annulus (Fig. 4 and Fig. 5).36 
This finding would be considered counter-intuitive, if the particulate reflectivity represents 
only cone photoreceptors, because histology suggests impaired cone survival over stage 3 
subretinal drusenoid deposits.7, 14 However, for a large proportion of stage 3 lesions seen by 
SD-OCT, the lesion apex bumped up against the ELM or poked through it (Figures 4 and 5). 
Therefore, any en face image that showed inner segments of surrounding cones also had to 
contain a reflective core attributable to the lesion itself. In a separate report, we confirmed 
this interpretation using AOSLO and AO assisted SD-OCT to view single subretinal 
drusenoid deposits in both en face and cross-sectional planes.36 The AO SD-OCT clearly 
revealed a pile of hyper-reflective granules. AOSLO imaging at different focal planes 
showed that the central granules, while manifesting variable reflectivity with the change of 
light focus, retained a fairly stable packing structure. This strongly suggests that the 
speckled texture in both modes arises from the granular nature of the lesions. However, the 
flood illumination AO fundus camera was unable to reveal these structures to the extent 
presented by AOSLO. Thus, if counts of cones over subretinal drusenoid deposits assessed 
by Mrejen et al were included non-photoreceptor reflectivity in this manner,18 then the 
severe photoreceptor degeneration associated with stage 3 subretinal drusenoid deposits 
reported by those authors may actually be worse.
Our study supports the hypothesis that pseudodrusen appearance is attributable to subretinal 
drusenoid deposits. Given the AOSLO focusing plane in the retina, the axial resolution, and 
clear photoreceptor mosaic in retina surrounding subretinal drusenoid deposits, reduced 
photoreceptor reflectivity associated with stage 1 and 2 subretinal drusenoid deposits 
represents alterations in the subretinal space. For stage 3 subretinal drusenoid deposits, 
photoreceptors and space-occupying materials clearly imaged by OCT are also in the same 
focal plane. Our most definitive evidence is that all 342 pseudodrusen identified in 
registered AOSLO, color, IR, RF, and AF images were examined in SD-OCT volume scans 
and found in the subretinal space. Further, a pseudodrusen subtype that extends into 
peripheral retina beyond the range of our AOSLO imaging in this study also localizes 
exclusively to the subretinal space.11 On the basis of these two datasets, pseudodrusen and 
subretinal drusenoid deposits appear to be one and the same, although any individual lesion 
in any individual eye may be better visualized with one imaging modality or another. Any 
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pseudodrusen in the macula that are not also subretinal drusenoid deposits may thus be rare 
to non-existent. As the name pseudodrusen implies something false, we recommend the 
subretinal drusenoid deposits terminology for these lesions, as visualized in all modalities.
This study has identified areas requiring future research. Subretinal drusenoid deposits have 
been classified into multiple subtypes, of which we measured the size of solitary lesions 
only, recently termed dots.11 Our classification system remains subjective, and we measured 
the size of subretinal drusenoid deposits manually. Confirmation of photoreceptor 
perturbation via functional assays like microperimetry would be ideal. Although a physical 
object in the subretinal space well explains pseudodrusen appearance, formation of these 
lesions is multifactorial. Additional insights into subretinal drusenoid deposits biogenesis 
will require detailed imaging studies directed toward factors that we did not herein address 
due to limitations of current AOSLO technology. These include RPE status (via fundus 
autofluorescence) and choroidal physiology (via enhanced depth imaging, phase sensitive 
OCT, or OCT with longer wavelength imaging light). The latter is important given current 
interest in the complex role of choroidal thickness.59–62 In a histologic study of 22 eyes of 
20 donors with early AMD choriocapillary ghosts were seen in 12.7% of regions under 
subretinal drusenoid deposits as compared with 7.7% lacking lesions; 14 such relative 
preservation was not visualized in vivo.10, 63
In conclusion, our study presents an improved description with multimodal high resolution 
imaging of a major component of AMD pathology localizing to the subretinal space. If 
extended with longitudinal data in more patients, these results would deepen our mechanistic 
understanding of AMD and how it is studied. Subretinal drusenoid deposits are inadequately 
represented in the AMD grading systems that provide the basis of population prevalence 
estimates and genetic associations, including a recent system that developed 
contemporaneously with high-resolution imaging studies hinting at the magnitude of these 
lesions.64 Proper functioning of photoreceptors depends on a bi-directional transport of 
molecules between them and the RPE that could be inhibited by material occupying space in 
the subretinal space. Extracellular material in the subretinal space lacks intrinsic cellular 
anti-oxidant systems, perhaps rendering this material susceptible to oxidative damage with 
pro-angiogenic outcomes. Our data strengthen the reality of subretinal drusenoid deposits 
and help motivate new studies to understand their significance.
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Figure 1. 
Photoreceptors in a healthy retina imaged by adaptive optics scanning laser ophthalmoscopy 
(AOSLO) and spectral domain optical coherence tomography (SD-OCT) with enhanced 
depth imaging. The subject (AMD-051) is a 54-year-old man (Age-Related Eye Disease 
Study grade 1, best-corrected visual acuity 20/20). (Top row, left) Digital color fundus 
photograph of 30° field of vie w. (Top row, right) AOSLO montage in grayscale is overlaid 
on the fundus photograph. (Middle) SD-OCT B-Scans taken through the green arrow-line in 
the top-right panel show parallel and evenly reflective bands of the external limiting 
membrane (ELM), ellipsoidal zone (EZ), and the retinal pigment epithelium (RPE)-Bruch 
complex, with negligible diffuse accumulations between the EZ and RPE-Bruch complex. 
(Bottom row) AOSLO images contained in the boxes of the top-right panel, revealing clear 
photoreceptor mosaic. (Bottom row, left) Photoreceptors in the peripheral retina, box 1 in 
the top-right panel. Large, bright dots are cones, surrounded by smaller, dimmer dots 
representing rods. (Bottom row, right) Image was taken in the parafovea, box 2 in the top-
right panel, most cells are cones. The dark band is the shadow of a retinal capillary. The 
reflectivity of individual photoreceptor varies,46 but there is no significant change of areal 
reflectivity on the retina.
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Figure 2. 
Photoreceptors overlying a stage 1 subretinal drusenoid deposit imaged by adaptive optics 
scanning laser ophthalmoscopy (AOSLO) and spectral domain optical coherence 
tomography (SD-OCT) with enhanced depth imaging. The subject (AMD-058) is a 76-year-
old woman with non-neovascular age-related macular degeneration (Age-Related Eye 
Disease Study grade 4, best-corrected visual acuity 20/25). (Top row, left) Digital color 
fundus photograph of 30° field of vie w. (Top row, right) AOSLO in gray scale is overlaid 
on the fundus photograph. (Middle) A SD-OCT B-Scan taken along the green arrow-line in 
top-right panel, showing undulating external limiting membrane (ELM) and ellipsoidal zone 
(EZ) bands. Diffuse deposition of granular hyper-reflective material between the retinal 
pigment epithelium (RPE) and the EZ is clearly observable at higher magnification in the 
bottom-right panel. (Bottom row, left) An AOSLO image of the area contained in box of the 
top-right panel reveals that photoreceptor mosaic overlaying a subretinal drusenoid deposit, 
delineated by the yellow boundary line, is undetectable and overall reflectivity is reduced.
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Figure 3. 
Photoreceptors overlying a stage 2 subretinal drusenoid deposit imaged by adaptive optics 
scanning laser ophthalmoscopy (AOSLO) and spectral domain optical coherence 
tomography (SD-OCT) with enhanced depth imaging. The subject (AMD-041) is a 73-year-
old man with non-neovascular AMD (Age-Related Eye Disease Study grade 6, best-
corrected visual acuity 20/25). (Top row, left) Digital color fundus photograph of 30° field 
of view. (Top row, right) A OSLO montage in grayscale is overlaid on the fundus 
photograph. (Middle) A SD-OCT B-Scan taken along the green arrow-line in top-right panel 
shows that external limiting membrane (ELM) and ellipsoidal zone (EZ) bands are 
significantly altered by a large subretinal drusenoid deposit between the retinal pigment 
epithelium (RPE) and the EZ bands (magnified in the bottom-right panel). (Bottom row, 
left), An AOSLO image of the boxed region of panel A shows that photoreceptors overlying 
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the subretinal drusenoid deposit, delineated by the yellow boundary line, are invisible, and 
overall reflectivity is further reduced.
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Figure 4. 
A distinctive hyporeflective annulus with internal granular reflectivity typifies stage 3 
subretinal drusenoid deposits imaged by adaptive optics scanning laser ophthalmoscopy 
(AOSLO) and spectral domain optical coherence tomography (SD-OCT) with enhanced 
depth imaging. The subject (AMD-63) is an 83-year-old man with non-neovascular age-
related macular degeneration (Age-Related Eye Disease Study grade 7, best-corrected visual 
acuity 20/30). (Top row, left) Digital color fundus photograph of 30° field of view. (Top 
row, right) A OSLO montage in grayscale is overlaid on the fundus photograph. (Middle 
row) A SD-OCT B-Scan taken along the green arrow-line in the top-right panel shows that a 
large subretinal drusenoid deposit has interrupted the photoreceptor ellipsoidal zone (EZ) 
band and expanded into the external limiting membrane (ELM) band, shown at higher 
magnification in the bottom-right panel. (Bottom row, left) The AOSLO image of the 
contained in the box of the top-right panel reveals over the subretinal drusenoid deposit a 
hyporeflective ring surrounding a granular hyper-reflective center area. The hyporeflective 
ring corresponds to the ‘gap’ in the photoreceptor EZ on either side of the subretinal 
drusenoid deposits.
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Figure 5. 
Subretinal drusenoid deposit shape and location characterized by 3D and high-resolution 
imaging deposits imaged by adaptive optics scanning laser ophthalmoscopy (AOSLO) and 
spectral domain optical coherence tomography (SD-OCT). The subject (AMD-041) is a 73-
year-old man with non-neovascular age-related macular degeneration (Age-Related Eye 
Disease Study grade 6, best-corrected visual acuity 20/25). (Top row) AOSLO image, cone 
photoreceptors are represented by evenly spaced hyper-reflective spots outside the annuli of 
hyper-reflectivity. The dark vertical bands are the shadows of overlying retinal blood 
vessels. The yellow and red arrowheads indicate a prominent stage 3 and stage 2 subretinal 
drusenoid deposits in superior perifovea, respectively, followed through the remaining 
panels. (Middle row, left and middle) OCT scans through these subretinal drusenoid 
deposits, as marked by the green line S1 and S2 in the top row panel. The stage 3 subretinal 
drusenoid deposit lifts the external limiting membrane (ELM) upward and is associated with 
a crowning tuft of hyper-reflectivity within the inner outer nuclear layer (ONL), representing 
perturbed Henle fibers.58, 65, 66 The stage 2 subretinal drusenoid deposit indents but does not 
interrupt the photoreceptor ellipsoidal zone (EZ). (Middle row, right) Magenta lines mark 
the planes where en-face OCT images, shown in the bottom row panels from left to right, 
were extracted from the 3D volume OCT scan. AOSLO image was an integration of the 
light reflected from depth 1 through 4. (Bottom row, far left) The top of a stage 3 subretinal 
drusenoid deposits has reached the hypo-reflective band internal to ELM. The stage 3 
subretinal drusenoid deposit manifests as a highly reflective area on the en face OCT image. 
(Bottom row, left) at the level near the EZ, the stage 3 subretinal drusenoid deposit becomes 
larger than at its apex. The stage 2 subretinal drusenoid deposit is barely eligible at this 
level. (Bottom row, right) at the middle of the EZ, the stage 3 subretinal drusenoid deposit is 
larger still, and a dark annulus appears; so does the stage 2 subretinal drusenoid deposit. 
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(Bottom row, far right) Near the retinal pigment epithelium (RPE), the hyper-reflective 
center and hyporeflective annulus of the stage 3 subretinal drusenoid deposit are at their 
largest. However, the stage 2 subretinal drusenoid deposit is indistinct at this level. The 
stage 3 subretinal drusenoid deposit shows a wide hyporeflective ring with indistinct 
borders. The ‘gap’ in the EZ on either side of subretinal drusenoid deposits in the OCT B-
scan corresponds to the hyporeflective annulus on the en-face OCT and the AOSLO image.
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TABLE
Subretinal drusenoid deposits and subretinal drusenoid deposits-associated impact on photoreceptors
Size Stage 1 Stage 2 Stage 3
Inner diameter b Outer diameter c
Mean ± SD (μm)a 78.02 ± 23.60 92.55 ± 26.06 59.51 ± 19.87 123.30 ± 29.70
Range (μm) 43.37 – 159.56 43.37 – 169.07 25.89 – 131.16 66.03 – 235.85
aSD: standard deviation.
b
The diameters of the reflective cores of stage 3 subretinal drusenoid deposits.
c
The diameters of the hyporeflective annuli of stage 3 subretinal drusenoid deposits.
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